Manufacturers Life Insurance Company, The Affimed N.V. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.57 - $1.08 $31,435 - $59,562	-55,150 Closed	0 $0
Q4 2022 Aug 11, 2023	BUY	$1.1 - $2.45 $211 - $470	192 Added 0.35%	55,150 $68,000
Q4 2022 Feb 13, 2023	BUY	$1.1 - $2.45 $211 - $470	192 Added 0.35%	55,150 $68,000
Q3 2022 Aug 11, 2023	SELL	$1.96 - $3.32 $2,763 - $4,681	-1,410 Reduced 2.5%	54,958 $113,000
Q3 2022 Nov 03, 2022	SELL	$1.96 - $3.32 $2,763 - $4,681	-1,410 Reduced 2.5%	54,958 $113,000
Q2 2022 Aug 11, 2023	BUY	$2.27 - $4.86 $22,802 - $48,818	10,045 Added 21.68%	56,368 $156,000
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $22,802 - $48,818	10,045 Added 21.68%	56,368 $156,000
Q1 2022 Aug 11, 2023	SELL	$3.69 - $5.65 $32,571 - $49,872	-8,827 Reduced 16.01%	46,323 $202,000
Q1 2022 May 20, 2022	SELL	$3.69 - $5.65 $47,851 - $73,269	-12,968 Reduced 21.87%	46,323 $202,000
Q4 2021 Feb 16, 2022	BUY	$5.37 - $7.07 $1,508 - $1,986	281 Added 0.48%	59,291 $327,000
Q3 2021 Nov 12, 2021	SELL	$5.54 - $7.51 $24,708 - $33,494	-4,460 Reduced 7.03%	59,010 $365,000
Q2 2021 Aug 12, 2021	BUY	$7.78 - $11.4 $7,577 - $11,103	974 Added 1.56%	63,470 $539,000
Q1 2021 May 03, 2021	BUY	$5.12 - $8.48 $60,682 - $100,504	11,852 Added 23.4%	62,496 $494,000
Q4 2020 Feb 12, 2021	BUY	$3.16 - $7.03 $21,535 - $47,909	6,815 Added 15.55%	50,644 $295,000
Q2 2020 Aug 10, 2020	SELL	$1.58 - $4.63 $6,236 - $18,274	-3,947 Reduced 8.26%	43,829 $198,000
Q1 2020 May 15, 2020	BUY	$1.44 - $3.02 $15,518 - $32,546	10,777 Added 29.13%	47,776 $75,000
Q4 2019 Feb 14, 2020	SELL	$2.25 - $3.07 $6,385 - $8,712	-2,838 Reduced 7.12%	36,999 $97,000
Q2 2019 Aug 14, 2019	BUY	$2.6 - $4.21 $103,576 - $167,713	39,837 New	39,837 $114,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $318M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account